• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Replies
1K
Views
479K
Replies
2
Views
369
Replies
74
Views
9K
Replies
13
Views
2K